Toward Gene Transfer Nanoparticles as Therapeutics.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Gene Therapy

Background:

• Gene medicine offers precise disease treatment but faces delivery challenges.
• Nanoparticles mimic viral delivery with enhanced safety and targeting.
• Nonviral gene transfer nanoparticles are rapidly progressing in clinical settings.

Purpose of the Study:

• To review the advancements in nanoparticle-based gene delivery systems.
• To highlight challenges and opportunities in nanomaterial-based gene transfer.
• To discuss clinical applications of gene therapy using nanomaterials.

Main Methods:

• Review of current literature on nanoparticle gene delivery.
• Discussion of various nanomaterials and their gene transfer capabilities (DNA, mRNA, ribonucleoproteins).
• Analysis of clinical progress and FDA-approved formulations.

Main Results:

• Multiple nonviral nanoparticle formulations are FDA-approved for gene expression and silencing.
• Lipid nanoparticles show significant progress, alongside other nanomaterials with favorable attributes.
• Nanomaterials offer biodegradability, scalability, and cell-targeting advantages.

Conclusions:

• Engineered nanomaterials are crucial for overcoming gene delivery challenges.
• Nanoparticle technology enables precise and effective gene transfer for genetic diseases.
• Future opportunities include long-term therapeutic gene editing using advanced delivery systems.